Cargando…
Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
Aims/Introduction: Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefor...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015543/ https://www.ncbi.nlm.nih.gov/pubmed/24843474 http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x |
_version_ | 1782315353192267776 |
---|---|
author | Uzui, Hiroyasu Nakano, Akira Mitsuke, Yasuhiko Geshi, Toru Sakata, Junji Sarazawa, Katsuhiko Morishita, Tetsuji Satou, Takehiko Ishida, Kentarou Lee, Jong‐Dae |
author_facet | Uzui, Hiroyasu Nakano, Akira Mitsuke, Yasuhiko Geshi, Toru Sakata, Junji Sarazawa, Katsuhiko Morishita, Tetsuji Satou, Takehiko Ishida, Kentarou Lee, Jong‐Dae |
author_sort | Uzui, Hiroyasu |
collection | PubMed |
description | Aims/Introduction: Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α‐GI leads to an improvement in arterial stiffness. Materials and Methods: A total of 22 patients with type 2 diabetes mellitus were treated with acarbose. Cardio‐ankle vascular index (CAVI) as the arterial stiffness was measured by using a VaSera CAVI instrument before and 12 months after acarbose treatment. Serum high‐sensitivity C‐reactive protein (hs‐CRP), pentraxin‐3 (PTX3) and matrix metalloproteinase (MMP) ‐2, ‐9 were measured at the same time points. Furthermore, circulating peripheral blood mononuclear cells were examined for the frequencies of CD14 positive cells expressing membrane type‐1 MMP (MT1‐MMP) at the single cell level using flow cytometry. Results: After acarbose treatment, postprandial glucose and glycosylated hemoglobin (HbA(1c)) were significantly decreased. Serum levels of hs‐CRP, PTX3, MMP‐2 and MMP‐9 were significantly decreased. CAVI showed a significant reduction, although the changes were not significant in blood pressure and heart rate. MT1‐MMP expression was significantly decreased by acarbose treatment. In multivariate analysis, improvement of blood glucose, decrease of PTX3 levels and MT1‐MMP expression were independent predictors of beneficial change in CAVI. Conclusions: The present study showed that the beneficial effects of acarbose on arterial stiffness are mediated by an improvement of postprandial hyperglycemia and vascular remodeling markers. In conclusion, acarbose treatment might reduce the risk of cardiovascular diseases by altering the arterial stiffness in postprandial hyperglycemic status. (J Diabetes Invest, doi:10.1111/j.2040‐1124.2010.00079.x, 2010) |
format | Online Article Text |
id | pubmed-4015543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40155432014-05-19 Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus Uzui, Hiroyasu Nakano, Akira Mitsuke, Yasuhiko Geshi, Toru Sakata, Junji Sarazawa, Katsuhiko Morishita, Tetsuji Satou, Takehiko Ishida, Kentarou Lee, Jong‐Dae J Diabetes Investig Articles Aims/Introduction: Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α‐GI leads to an improvement in arterial stiffness. Materials and Methods: A total of 22 patients with type 2 diabetes mellitus were treated with acarbose. Cardio‐ankle vascular index (CAVI) as the arterial stiffness was measured by using a VaSera CAVI instrument before and 12 months after acarbose treatment. Serum high‐sensitivity C‐reactive protein (hs‐CRP), pentraxin‐3 (PTX3) and matrix metalloproteinase (MMP) ‐2, ‐9 were measured at the same time points. Furthermore, circulating peripheral blood mononuclear cells were examined for the frequencies of CD14 positive cells expressing membrane type‐1 MMP (MT1‐MMP) at the single cell level using flow cytometry. Results: After acarbose treatment, postprandial glucose and glycosylated hemoglobin (HbA(1c)) were significantly decreased. Serum levels of hs‐CRP, PTX3, MMP‐2 and MMP‐9 were significantly decreased. CAVI showed a significant reduction, although the changes were not significant in blood pressure and heart rate. MT1‐MMP expression was significantly decreased by acarbose treatment. In multivariate analysis, improvement of blood glucose, decrease of PTX3 levels and MT1‐MMP expression were independent predictors of beneficial change in CAVI. Conclusions: The present study showed that the beneficial effects of acarbose on arterial stiffness are mediated by an improvement of postprandial hyperglycemia and vascular remodeling markers. In conclusion, acarbose treatment might reduce the risk of cardiovascular diseases by altering the arterial stiffness in postprandial hyperglycemic status. (J Diabetes Invest, doi:10.1111/j.2040‐1124.2010.00079.x, 2010) Blackwell Publishing Ltd 2011-04-07 2010-11-03 /pmc/articles/PMC4015543/ /pubmed/24843474 http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x Text en © 2010 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd |
spellingShingle | Articles Uzui, Hiroyasu Nakano, Akira Mitsuke, Yasuhiko Geshi, Toru Sakata, Junji Sarazawa, Katsuhiko Morishita, Tetsuji Satou, Takehiko Ishida, Kentarou Lee, Jong‐Dae Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title | Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title_full | Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title_fullStr | Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title_full_unstemmed | Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title_short | Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
title_sort | acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015543/ https://www.ncbi.nlm.nih.gov/pubmed/24843474 http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x |
work_keys_str_mv | AT uzuihiroyasu acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT nakanoakira acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT mitsukeyasuhiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT geshitoru acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT sakatajunji acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT sarazawakatsuhiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT morishitatetsuji acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT satoutakehiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT ishidakentarou acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus AT leejongdae acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus |